Gabriel S. Morris

CIK: 0001889967

Transaction Breakdown

Open Market Buys (P)3 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMX

Immix Biopharma, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

IMMX
Immix Biopharma, Inc.
May 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
500K shares-
IMMX
Immix Biopharma, Inc.
Dec 10, 2025
Purchase(P)
Direct
770 shares at avg. $6.58$5K
IMMX
Immix Biopharma, Inc.
Dec 8, 2025
In-the-Money(X)
Indirect
156K shares at avg. $0.80$125K
IMMX
Immix Biopharma, Inc.
Sep 16, 2025
Purchase(P)
Direct
2.6K shares at avg. $1.97$5K
IMMX
Immix Biopharma, Inc.
Jun 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
340K shares-
IMMX
Immix Biopharma, Inc.
Jun 18, 2025
Purchase(P)
Direct
2.2K shares at avg. $2.28$5K

		Type	Shares	Price		Ownership
May 22, 2026	IMMX Immix Biopharma, Inc.	Award(A) Stock Option (Right to Buy)	500,000	-	-	Direct
Dec 10, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	770	$6.58	$5,067	Direct
Dec 8, 2025	IMMX Immix Biopharma, Inc.	In-the-Money(X)	156,000	$0.80	$124,800	Indirect
Sep 16, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	2,600	$1.97	$5,122	Direct
Jun 20, 2025	IMMX Immix Biopharma, Inc.	Award(A) Stock Option (Right to Buy)	340,000	-	-	Direct
Jun 18, 2025	IMMX Immix Biopharma, Inc.	Purchase(P)	2,225	$2.28	$5,071	Direct

1-6 of 6 transactions

About Morris Gabriel S

Morris Gabriel S (SEC CIK 0001889967) files insider reports with the SEC as CFO, President of Immix Biopharma, Inc. (IMMX).

Signal8 holds 5 ownership filings by Morris Gabriel S, all Form 4s, filed between Jun 20, 2025 and May 29, 2026. Those filings report 6 transactions, from Jun 18, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Morris Gabriel S's filings is in LOS ANGELES, CA.

Recent filings by Morris Gabriel S

May 22, 2026: Grant or award of IMMX derivative securities (Form 4, code A).
Dec 10, 2025: Open-market purchase of IMMX shares (Form 4, code P).
Dec 8, 2025: Option exercise of IMMX shares (Form 4, code X).
Sep 16, 2025: Open-market purchase of IMMX shares (Form 4, code P).
Jun 20, 2025: Grant or award of IMMX derivative securities (Form 4, code A).

Other insiders filing for Immix Biopharma, Inc. (IMMX)

Adams Helen C., Director
Ng Carey, Director
Marquet Magda, Director
CHANG NANCY T, Director
Rachman Ilya M, CEO and Chairman
Chudnovsky Yekaterina, Director

How to read Form 4 transaction codes